Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.47 |
| ▸ | CCR1 | P32246 | 1/20 | 0.44 |
| ▸ | CCR5 | P51681 | 1/20 | 0.44 |
| ▸ | CCR8 | P51685 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | PRKDC | P78527 | 5/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.40 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | DRD4 | P21917 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29881874 | 1.00 | ALOX5 (0.47) | ALOX5CCR1CCR5CCR8NPC1 | |
| SCHEMBL21204223 | 0.94 | MAOA (0.43) | ALOX5CCR1CCR5CCR8NPC1 | |
| SCHEMBL26349380 | 0.90 | CCR1 (0.43) | ALOX5CCR1CCR5CCR8NPC1 | |
| SCHEMBL15696755 | 0.88 | CCR1 (0.41) | ALOX5CCR1CCR5CCR8NPC1 | |
| SCHEMBL15696757 | 0.87 | CYP2A6 (0.43) | ALOX5CCR1CCR5CCR8NPC1 | |
| SCHEMBL15696750 | 0.87 | CYP2A6 (0.43) | ALOX5CCR1CCR5CCR8NPC1 | |
| SCHEMBL24425927 | 0.85 | CCR1 (0.39) | ALOX5CCR1CCR5CCR8PRKDC | |
| SCHEMBL26042989 | 0.85 | ALOX5 (0.47) | ALOX5NPC1RAB9APRKDCALDH1A1 | |
| SCHEMBL15696769 | 0.85 | CYP2A6 (0.41) | ALOX5CCR1CCR5CCR8NPC1 | |
| SCHEMBL15696768 | 0.84 | SMN1; SMN2 (0.43) | CCR1CCR5CCR8NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4701391-A2 | HETEROLEPTIC IRIDIUM COMPLEX | Universal Display Corporation (US) | 2026-02-25 | — | — | EP | disclosed |
| US-12550604-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2026-02-10 | — | — | US | disclosed |
| EP-3643721-B1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORP (US) | 2026-01-28 | — | — | EP | disclosed |
| US-20250338370-A1 | HETEROLEPTIC IRIDIUM COMPLEXES AS DOPANTS | UNIVERSAL DISPLAY CORPORATION (US) | 2025-10-30 | — | — | US | disclosed |
| US-12448403-B2 | Organometallic compound, organic light-emitting device including organometallic compound, and electronic apparatus including organic light-emitting device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-10-21 | — | — | US | disclosed |
| US-12408242-B2 | Heteroleptic iridium complexes as dopants | UNIVERSAL DISPLAY CORPORATION (US) | 2025-09-02 | — | — | US | disclosed |
| US-12310229-B2 | Organometallic compound, organic light-emitting device including organometallic compound, and electronic apparatus including organic light-emitting device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-05-20 | — | — | US | disclosed |
| US-20240180020-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-05-30 | — | — | US | disclosed |
| US-20240138251-A1 | HETEROLEPTIC IRIDIUM COMPLEXES AS DOPANTS | UNIVERSAL DISPLAY CORPORATION (US) | 2024-04-25 | — | — | US | disclosed |
| US-11910701-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2024-02-20 | — | — | US | disclosed |
| US-20130026452-A1 | HETEROLEPTIC IRIDIUM COMPLEXES AS DOPANTS | UNIVERSAL DISPLAY CORPORATION (US) | 2013-01-31 | — | — | US | disclosed |
| US-20130026452-A1 | HETEROLEPTIC IRIDIUM COMPLEXES AS DOPANTS | UNIVERSAL DISPLAY CORPORATION (US) | 2013-01-31 | — | — | US | disclosed |
| EP-2551933-A1 | Heteroleptic iridium complexes as dopants | Universal Display Corporation (US) | 2013-01-30 | — | — | EP | disclosed |
| EP-2551933-A1 | Heteroleptic iridium complexes as dopants | Universal Display Corporation (US) | 2013-01-30 | — | — | EP | disclosed |
| EP-2411401-A1 | HETEROLEPTIC IRIDIUM COMPLEX | Universal Display Corporation (US) | 2012-02-01 | — | — | EP | disclosed |
| US-20100244004-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2010-09-30 | — | — | US | disclosed |
| US-20100244004-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2010-09-30 | — | — | US | disclosed |
| US-20100244004-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2010-09-30 | — | — | US | disclosed |
| WO-2010111175-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2010-09-30 | — | — | WO | disclosed |
| WO-2010111175-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2010-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11910701-B2 | Organic electroluminescent materials and devices | ICOSLG, PDCD1LG2, NECTIN4 | ALOX5 1110/4885CCR1 3962/4885CCR5 2200/4885 |
| US-12408242-B2 | Heteroleptic iridium complexes as dopants | JUND, DRD2, DRD1 | ALOX5 324/4885CCR1 4248/4885CCR5 1635/4885 |
| US-12310229-B2 | Organometallic compound, organic light-emitting device including organometallic compound, and electronic apparatus including organic light-emitting device | L1CAM, AP1M1, AP2M1 | ALOX5 2795/4885CCR1 2331/4885CCR5 3409/4885 |
| US-20250338370-A1 | HETEROLEPTIC IRIDIUM COMPLEXES AS DOPANTS | JUND, DRD2, DRD1 | ALOX5 324/4885CCR1 4248/4885CCR5 1635/4885 |
| US-20240180020-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ICOSLG, PDCD1LG2, NECTIN4 | ALOX5 1110/4885CCR1 3962/4885CCR5 2200/4885 |
| US-20240138251-A1 | HETEROLEPTIC IRIDIUM COMPLEXES AS DOPANTS | JUND, DRD2, DRD1 | ALOX5 324/4885CCR1 4248/4885CCR5 1635/4885 |
| US-20130026452-A1 | HETEROLEPTIC IRIDIUM COMPLEXES AS DOPANTS | JUND, DRD2, DRD1 | ALOX5 324/4885CCR1 4248/4885CCR5 1635/4885 |
| US-12448403-B2 | Organometallic compound, organic light-emitting device including organometallic compound, and electronic apparatus including organic light-emitting device | L1CAM, AP1M1, CHRM1 | ALOX5 2912/4885CCR1 1489/4885CCR5 2365/4885 |
| US-20100244004-A1 | HETEROLEPTIC IRIDIUM COMPLEX | DDT, ICOSLG, PDCD1LG2 | ALOX5 680/4885CCR1 3836/4885CCR5 1536/4885 |
| US-12550604-B2 | Organic electroluminescent materials and devices | ROS1, DNMT3A, PRDM9 | ALOX5 3699/4885CCR1 3354/4885CCR5 2607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.